Study on amniotic fluid metabolism in the second trimester of Trisomy 21
Open Access
- 10 November 2019
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 34 (3) , e23089
Abstract
Background: Trisomy 21 is a common aneuploid condition in humans and accounts for approximately one quarter of all aneuploid live births. To date, early diagnosis of Trisomy 21 remains a challenging task. Metabolomics may prove an innovative tool to study the early pathophysiology of Trisomy 21 at a functional level.Methods: Ultra‐performance liquid chromatography coupled with mass spectrometer (UPLC‐MS) was used for untargeted metabolomic analysis of amniotic fluid samples from women having normal and trisomy 21 fetuses.Results: Many significantly changed metabolites were identified between amniotic fluid samples from Trisomy 21 pregnancies and normal euploid pregnancies, such as generally lower levels of several steroid hormones and their derivatives, higher levels of glutathione catabolites coupled with lower levels of gamma‐glutamyl amino acids, and increased levels of phospholipid catabolites, sugars, and dicarboxylic acids. The identification of a human milk oligosaccharide in amniotic fluid may worth further investigation, since confirmation of this observation may have significant implications for regulation of fetal development.Conclusions: The metabolisms in amniotic fluid from Trisomy 21 and normal pregnancies are quite different, and some of the significantly changed metabolites may be considered as candidates of early diagnostic biomarkers for Trisomy 21.Keywords
This publication has 32 references indexed in Scilit:
- UPLC-MS metabolic profiling of second trimester amniotic fluid and maternal urine and comparison with NMR spectral profiling for the identification of pregnancy disorder biomarkersMolecular BioSystems, 2012
- Impact of Prenatal Disorders on the Metabolic Profile of Second Trimester Amniotic Fluid: A Nuclear Magnetic Resonance Metabonomic StudyJournal of Proteome Research, 2010
- Metabolomics in premature labor: a novel approach to identify patients at risk for preterm deliveryThe Journal of Maternal-Fetal & Neonatal Medicine, 2010
- Maternal urine and serum steroid measurements to identify steroid sulfatase deficiency (STSD) in second trimester pregnanciesPrenatal Diagnosis, 2009
- GDPD5 is a glycerophosphocholine phosphodiesterase that osmotically regulates the osmoprotective organic osmolyte GPCProceedings of the National Academy of Sciences, 2008
- Cortisol: The Culprit Prenatal Stress VariableInternational Journal of Neuroscience, 2008
- Prenatal in situ hybridization test for deleted steroid sulfatase geneAmerican Journal of Medical Genetics, 1993
- Amniotic fluid alpha‐fetoprotein, gamma‐glutamyltranspeptidase, and autosomal trisomiesPrenatal Diagnosis, 1989
- Biosynthesis of 5‐Aminopentanoic Acid and 2‐Piperidone from Cadaverine and 1‐Piperideine in MouseJournal of Neurochemistry, 1984
- THE SIGNIFICANCE OF STEROID HORMONES FOR THE DEVELOPMENT OF HYPERBILIRUBINAEMIA AND ICTERUS IN THE NEWBORN INFANTJournal of Endocrinology, 1967